Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 27 of 6351
-
Can a blood thinner plus progesterone prevent recurrent miscarriages?
Disease control Not yet recruitingThe objective of the trial is to assess whether the combination of enoxaparine (LMWH) with progesterone increases the live birth rate compared to standard of care (no active treatment) in women with unexplained recurrent pregnancy loss.
Phase 3 • Sponsor: General University Hospital, Prague • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Can a new drug combo outsmart Hard-to-Treat myeloma?
Disease control Not yet recruitingMultiple myeloma (MM) is a plasma cell malignancy characterized by the proliferation of clonal plasma cells in the bone marrow. The disease primarily localizes to the bones and bone marrow, with resultant cytopenias, bone pain, fractures, infections, hypercalcemia, and renal fail…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a Triple-Drug cocktail outsmart resistant leukemia?
Disease control Recruiting nowTo evaluate the efficacy and safety of venetoclax, chidamide, and chiglitazar sodium (VCC) in patients with relapsed or refractory acute myeloid leukemia (R/R AML).
Phase 2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a new pill ease muscle weakness in myositis?
Disease control Not yet recruitingThis study is open to adults aged 18 and older who have a condition known as active idiopathic inflammatory myopathy (IIM) or myositis. People can participate if they have a specific type of myositis. The purpose of this study is to find out whether a medicine called nerandomilas…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
One pill to stop the flu from spreading at home? a new trial puts sebaloxavir to the test.
Prevention Not yet recruitingThis study is a randomized, double-blind, placebo-controlled phase III clinical trial. The trial participants include index participants (IP) and household contacts (HHC). A total of 536 index participants (the first person in the household diagnosed with influenza) and 858 house…
Phase 3 • Sponsor: Nanjing Zenshine Pharmaceuticals • Aim: Prevention
Last updated Jul 30, 2026 00:00 UTC
-
One pill to wipe out worms? new trial tests Game-Changing treatment
Cure Not yet recruitingThis study aims to assess the efficacy and safety of emodepside compared to mebendazole in adults and adolescents infected with T. trichiura, either as single infection or co-infections with hookworm and/or A. lumbricoides.
Phase 3 • Sponsor: Swiss Tropical & Public Health Institute • Aim: Cure
Last updated Aug 16, 2026 00:00 UTC
-
Can freezing breast tumors replace the scalpel?
Disease control Not yet recruitingThe goal of this clinical trial is to study cryoablation as a treatment for selected adults with localized breast cancer. Cryoablation uses very low temperatures to destroy the tumor through thin needles placed through the skin under ultrasound guidance. The main questions this …
Sponsor: Ospedale Cottolengo • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Radiation boost may extend Drug-Free time in prostate cancer recurrence
Disease control Not yet recruitingThe goal of this clinical trial is to learn if adding metastasis-directed radiotherapy with or without pelvic salvage radiotherapy, to intermittent prostate cancer drugs (intensified hormone therapy) can delay the need to restart these drugs in men with oligometastactic prostate …
Phase 3 • Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a Weight-Loss drug boost Fertility-Sparing cancer treatment?
Disease control Not yet recruitingThis is a prospective, multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial designed to evaluate the efficacy and safety of mazdutide combined with a levonorgestrel-releasing intrauterine system (LNG-IUS) for fertility-sparing treatment in over…
Phase 2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can new HIV drug mixes keep more children Virus-Free?
Disease control Not yet recruitingThe goal of the CHAPAS-5 clinical trial is to find out how well different HIV treatments work in children and young people (from 4 weeks up to under 15 years old) living with HIV, including those starting treatment for the first time and those whose current treatment is not worki…
Phase 3 • Sponsor: University College, London • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a targeted drug combo shrink Hard-to-Treat colorectal tumors?
Disease control Not yet recruitingThis global study is being conducted to evaluate the safety and determine the recommended phase 3 dose of trastuzumab rezetecan in combination with mFOLFOX6 chemotherapy (dose level -1) and bevacizumab as first-line treatment in participants with advanced colorectal cancer that e…
Phase 2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a targeted pill clear hidden lung cancer cells after surgery?
Disease control Not yet recruitingThis study will evaluate the novel, oral EGFR TKI, zipalertinib, in the adjuvant ctDNA-adapted treatment of stage IA2 to IIIC atypical EGFR-mutant NSCLC after completion of definitive therapy with a primary endpoint of molecular response in participants identified as having minim…
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a new drug stop the Body's attack after stem cell transplants?
Prevention Not yet recruitingThis is a randomized, multisite, Phase II study designed to compare the 1-year GVHD-free survival of the control arm (no axatilimab) to the experimental arm (axatilimab) after myeloablative allogeneic HCT.
Phase 2 • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
Could brain pacemakers slow Alzheimer's? new trial tests DBS
Disease control By invitation onlyThis project will investigate the potential of Deep Brain Stimulation to improve cognitive abilities and counteract the effects of Alzheimer's disease. Deep Brain Stimulation electrodes targeting the Nucleus Basalis of Meynert (NB) will be implanted bilaterally in a cohort of pat…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a new heart valve offer a safer fix for aortic stenosis?
Disease control Not yet recruitingThe objective of this pivotal, prospective, multicenter, single-arm clinical trial is to evaluate the safety and clinical performance of the Next-Generation INOVARE® SAFESYNC Bioprosthetic Heart Valve, implanted via a transcatheter approach, in patients with severe aortic stenosi…
Sponsor: Braile Biomedica Ind. Com. e Repr. Ltda. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New brain cancer wafer shows promise in recurrent glioblastoma trial
Disease control Not yet recruitingThis study is designed as a multi-center, randomized, open-label trial to evaluate the efficacy of Cerebraca Wafer in patients with recurrent glioblastoma. Cerebraca Wafer is intended for use in recurrent glioblastoma as an adjunct to surgery (followed by standard-of-care temozol…
Phase 2/3 • Sponsor: Everfront Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Gene therapy skin graft aims to heal wounds in 'Butterfly Children'
Disease control Not yet recruitingThe Master Protocol includes 3 studies (Study A, Study B, and Study C) that will evaluate pz-cel and related processes in the post-marketing setting. Study A investigates the efficacy and safety of non-conforming pz-cel in patients with Recessive Dystrophic Epidermolysis Bullosa…
Phase 4 • Sponsor: Abeona Therapeutics, Inc • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Blood test may tailor lung cancer immunotherapy, sparing unnecessary treatment
Disease control Not yet recruitingThe reference treatment for locally advanced (stage III) non-small cell lung cancer (NSCLC) is concomitant chemoradiotherapy (CRT) followed by durvalumab consolidation for 1 year. This strategy is based on the results of the PACIFIC trial, which compared, in a randomized fashion …
Phase 2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can an earthworm enzyme boost stroke recovery?
Disease control Not yet recruitingLUMEN is a multicenter, randomized, double-blind, placebo-controlled superiority trial designed to evaluate whether oral lumbrokinase enteric-coated capsules combined with aspirin improve functional outcomes compared with aspirin alone in patients with moderate-to-severe acute is…
Phase 4 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Could donor tissue replace metal knee implants?
Cure Not yet recruitingYoung patients who require total knee arthroplasty with metallic and plastic implants will undergo femoral condyle cartilage and top of the tibia with meniscus replacement. With the proposed surgery patients will have increased range of movements so that they can sit on the groun…
Early phase 1 • Sponsor: AlSalam Hospital • Aim: Cure
Last updated Aug 21, 2026 00:00 UTC